These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27485727)

  • 1. Theory-based modifications of an advanced notification letter improves screening for bowel cancer in men: A randomised controlled trial.
    Zajac IT; Duncan AC; Flight I; Wittert GA; Cole SR; Young GP; Wilson CJ; Turnbull DA
    Soc Sci Med; 2016 Sep; 165():1-9. PubMed ID: 27485727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An advance notification letter increases participation in colorectal cancer screening.
    Cole SR; Smith A; Wilson C; Turnbull D; Esterman A; Young GP
    J Med Screen; 2007; 14(2):73-5. PubMed ID: 17626705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial.
    van Roon AH; Hol L; Wilschut JA; Reijerink JC; van Vuuren AJ; van Ballegooijen M; Habbema JD; van Leerdam ME; Kuipers EJ
    Prev Med; 2011 Jun; 52(6):448-51. PubMed ID: 21457725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
    McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
    Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-notification and reminder SMS text messages with behaviourally informed invitation letters to improve uptake of NHS Health Checks: a factorial randomised controlled trial.
    Sallis A; Sherlock J; Bonus A; Saei A; Gold N; Vlaev I; Chadborn T
    BMC Public Health; 2019 Aug; 19(1):1162. PubMed ID: 31438908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trial.
    Koitsalu M; Eklund M; Adolfsson J; Grönberg H; Brandberg Y
    BMC Med Res Methodol; 2018 Jan; 18(1):3. PubMed ID: 29304734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
    Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.
    Wardle J; von Wagner C; Kralj-Hans I; Halloran SP; Smith SG; McGregor LM; Vart G; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas MC; Counsell N; Morris S; Duffy SW; Hackshaw A; Moss S; Atkin W; Raine R
    Lancet; 2016 Feb; 387(10020):751-9. PubMed ID: 26680217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.
    von Wagner C; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Macleod U; Duffy S
    BMJ Open; 2018 May; 8(5):e022263. PubMed ID: 29730633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted promotional DVD fails to improve Māori and Pacific participation rates in the New Zealand bowel screening pilot: results from a pseudo-randomised controlled trial.
    Bartholomew K; Zhou L; Crengle S; Buswell E; Buckley A; Sandiford P
    BMC Public Health; 2019 Sep; 19(1):1245. PubMed ID: 31500594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinvitation to screening colonoscopy: a randomized-controlled trial of reminding letter and invitation to educational meeting on attendance in nonresponders to initial invitation to screening colonoscopy (REINVITE).
    Pisera M; Kaminski MF; Kraszewska E; Rupinski M; Regula J
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):538-42. PubMed ID: 26967693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-notification increases uptake of colorectal cancer screening in all demographic groups: a randomized controlled trial.
    Libby G; Bray J; Champion J; Brownlee LA; Birrell J; Gorman DR; Crighton EM; Fraser CG; Steele RJ
    J Med Screen; 2011; 18(1):24-9. PubMed ID: 21536813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of an enhanced invitation letter on uptake of National Health Service Health Checks in primary care: a pragmatic quasi-randomised controlled trial.
    Sallis A; Bunten A; Bonus A; James A; Chadborn T; Berry D
    BMC Fam Pract; 2016 Mar; 17():35. PubMed ID: 27009045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner.
    Cole SR; Young GP; Byrne D; Guy JR; Morcom J
    J Med Screen; 2002; 9(4):147-52. PubMed ID: 12518003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.
    Stoop EM; de Haan MC; de Wijkerslooth TR; Bossuyt PM; van Ballegooijen M; Nio CY; van de Vijver MJ; Biermann K; Thomeer M; van Leerdam ME; Fockens P; Stoker J; Kuipers EJ; Dekker E
    Lancet Oncol; 2012 Jan; 13(1):55-64. PubMed ID: 22088831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for population testing of an Internet-based Personalised Decision Support system for colorectal cancer screening.
    Wilson CJ; Flight IH; Zajac IT; Turnbull D; Young GP; Cole SR; Gregory T
    BMC Med Inform Decis Mak; 2010 Sep; 10():50. PubMed ID: 20843369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening.
    Myers RE; Sifri R; Hyslop T; Rosenthal M; Vernon SW; Cocroft J; Wolf T; Andrel J; Wender R
    Cancer; 2007 Nov; 110(9):2083-91. PubMed ID: 17893869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.